ReviewPharmacogenomics and personalized medicine2014
ALK-driven tumors and targeted therapy: focus on crizotinib.
Carlos Murga-Zamalloa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it
ReviewPharmacogenomics and personalized medicine2014
Carlos Murga-Zamalloa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.